drugset / Trial / NCT01826851

Parasternal Nerve Block in Cardiac Patients

NCT01826851

Phase 2 Completed 79 enrolled University of Rochester
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Exparel is a new local analgesic (numbing medication) that is intended to be longer acting than currently available local analgesics. The purpose of this study is to determine whether use of Exparel to numb the nerves along the breastbone after open heart surgery, will decrease pain and pain medication use after surgery.

Timeline

Start
2013-03
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 266 mg Other